"Black box" warnings and generic name changes for botulinum products in US
05 August 2009
Katie McQue
Please Login to read the full article.
05 August 2009
Katie McQue
katie.mcque@informa.com
The US
FDA has added a "black box" warning to all botulinum-containing products, cautioning against "life-threatening" adverse events in cases where the toxin spreads beyond the injection site. The products' established drug names also have been changed to differentiate them and reduce the potential...
Please Login to read the full article.
RELATED CONTENT
NEWS
- European positive opinion for Allergan's Botox for neurogenic bladder incontinence
- Ipsen sells North American rights to Parkinson's drug to Britannia
- Back to the clinic as Fox supports trial of NeuroHealing's drooling drug in Parkinson's
- NICE drug wars: Tarceva vs Iressa, Revlimid vs IFN alpha, Botox vs SoC, and others
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
